➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Merck
AstraZeneca
Moodys
McKinsey

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CHIRHOSTIM

« Back to Dashboard

All Clinical Trials for Chirhostim

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00587132 Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma Terminated ChiRhoClin, Inc. Phase 1/Phase 2 2006-11-01 The purpose of this study is to test if secretin-enhanced CT is a useful noninvasive screening tool for pancreatic cancer in a high-risk population.
NCT00587132 Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma Terminated Mayo Clinic Phase 1/Phase 2 2006-11-01 The purpose of this study is to test if secretin-enhanced CT is a useful noninvasive screening tool for pancreatic cancer in a high-risk population.
NCT01087801 A Study of Synthetic Human Secretin (ChiRhoStim®) Administered Intravenously to Stimulate Exocrine Pancreas Fluid Secretion for Collection Via Endoscope and Laboratory Analysis of DNA Markers Completed ChiRhoClin, Inc. Phase 3 2007-10-01 The following are the study hypothesis: - Secretin administration compared to placebo will result in a statistically significantly greater percentage of collected fluid samples being predominantly of exocrine pancreas origin when samples are duodenal aspirates. - Secretin administration compared to placebo will result in a statistically significantly greater percentage of collected fluid samples meeting the minimum specifications for use in the indicated laboratory test of DNA mutational analysis.
NCT01265875 Secretin Infusion for Pain Due to Chronic Pancreatitis Completed Dartmouth-Hitchcock Medical Center Phase 1/Phase 2 2010-12-01 - To determine if intravenous secretin administration in escalating doses three times daily for three days will improve the pain from CP at the time of infusion, after each infusion (1 to 3 hours), at Day 7 after infusion, and at Day 30 after infusion. - To validate the safety of intravenous secretin administration at the dosage indicated in this study.
NCT01265875 Secretin Infusion for Pain Due to Chronic Pancreatitis Completed ChiRhoClin, Inc. Phase 1/Phase 2 2010-12-01 - To determine if intravenous secretin administration in escalating doses three times daily for three days will improve the pain from CP at the time of infusion, after each infusion (1 to 3 hours), at Day 7 after infusion, and at Day 30 after infusion. - To validate the safety of intravenous secretin administration at the dosage indicated in this study.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Chirhostim

Condition Name

Condition Name for Chirhostim
Intervention Trials
Chronic Pancreatitis 1
Pancreatic Disease 1
Abdominal Pain 1
Pancreatic Cancer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Chirhostim
Intervention Trials
Pancreatitis, Chronic 2
Pancreatitis 2
Pancreatic Diseases 1
Irritable Bowel Syndrome 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Chirhostim

Trials by Country

Trials by Country for Chirhostim
Location Trials
United States 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Chirhostim
Location Trials
Minnesota 2
Ohio 1
New Hampshire 1
Missouri 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Chirhostim

Clinical Trial Phase

Clinical Trial Phase for Chirhostim
Clinical Trial Phase Trials
Phase 3 2
Phase 1/Phase 2 3
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Chirhostim
Clinical Trial Phase Trials
Completed 2
Not yet recruiting 2
Terminated 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Chirhostim

Sponsor Name

Sponsor Name for Chirhostim
Sponsor Trials
ChiRhoClin, Inc. 5
Mayo Clinic 2
The National Pancreas Foundation 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Chirhostim
Sponsor Trials
Other 6
Industry 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Medtronic
Baxter
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.